As of January 22, 2025, Journey Medical (DERM) has a market cap of $76.875 million USD. According to our data, Journey Medical is ranked No.7885 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $76.87 M |
32.04%
|
Dec 31, 2024 | $58.22 M |
-32.12%
|
Dec 29, 2023 | $85.77 M |
200.00%
|
Dec 30, 2022 | $28.59 M |
-64.31%
|
Dec 31, 2021 | $80.11 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Journey Medical
DERM
|
$76.87 M |
22.080 M
|
USA
|
Revance Therapeutics
RVNC
|
$0.38 B |
0.000 M
|
USA
|
Arcutis Biotherapeutics
ARQT
|
$1.60 B |
0.000 M
|
USA
|
Verrica Pharmaceuticals
VRCA
|
$64.87 M |
0.000 M
|
USA
|
Evolus
EOLS
|
$0.89 B |
-0.000 M
|
USA
|
Sol-Gel Technologies
SLGL
|
$25.04 M |
0.000 M
|
Israel
|
Biofrontera
BFRI
|
$7.90 M |
0.000 M
|
USA
|
Aclaris Therapeutics
ACRS
|
$0.28 B |
-0.000 M
|
USA
|
DermTech
DMTK
|
$3.29 M |
3.287 M
|
USA
|
Intra-Cellular Therapies
ITCI
|
$13.51 B |
-0.000 M
|
USA
|
Krystal Biotech
KRYS
|
$4.41 B |
-0.000 M
|
USA
|
Market Cap | = | DERM Stock Price | * | DERM Shares Outstanding |
= | $3.68 | * | 14.89 M | |
= | $76.87 M |